Special Guest: Glenn Sabin
In 1991, Glenn Sabin was a 28-year-old newlywed diagnosed with chronic lymphocytic leukemia (CLL) – a disease doctors called “uniformly fatal.” Treatments could buy him some time and eventually ease his discomfort, but there was no conventional cure. Glenn’s prognosis was clear: he was going to die. Although Glenn and his wife, Linda, continued to consult with doctors, cancer specialists and top oncologists, Glenn made a monumental decision – he would become his own health advocate. No one could predict when a large-scale clinical trial would discover a cure for CLL, so Glenn began his own, medically monitored and carefully researched lifestyle changes. He conducted his own, single patient clinical trial.
Dana Laake and her special Anthony Thomas will discuss new advancements of Jarrow Formulas’ product, BroccoMax.
Anthony Thomas, Ph.D., serves on Jarrow Formulas’ Scientific Panel. His primary research interests have focused on the influence of dietary and lifestyle factors on the pathogenesis of chronic cardiovascular/metabolic diseases including obesity, insulin resistance syndrome, and type 2 diabetes. He has authored/co-authored multiple peer reviewed scientific manuscripts and contributed his expertise in the fields of nutrition, obesity, and diabetes for a number of scientific journals.
Dana Laake and her guest Dr. Nicholas Gonzalez will be discussing the Gonzalez approach to cancer.
Nicholas J. Gonzalez, M.D., graduated from Brown University, Phi Beta Kappa, magna cum laude, with a degree in English Literature. He subsequently worked as a journalist, first at Time Inc., before pursuing premedical studies at Columbia. He then received his medical degree from Cornell University Medical College in 1983. During a postgraduate immunology fellowship under Dr. Robert A. Good, considered the father of modern immunology, he completed a research study evaluating an aggressive nutritional therapy in the treatment of advanced cancer. Since 1987, Dr. Gonzalez has been in private practice in New York City, treating patients diagnosed with cancer and other serious degenerative illnesses. His nutritional research has received substantial financial support from Procter & Gamble, Nestle, and the National Cancer Institute. Results from a pilot study published in 1999 described the most positive data in the medical literature for pancreatic cancer.
Dana Laake and her special guest Victoria Wood will be discussing the use of branched-chain amino acids in cancer and anti-aging.
Victoria Wood, MPH, RD, CNS, has been practicing Medical Nutrition Therapy (MNT) for over 25 years. She specializes in designing programs for optimal genetic expression for a wide array of conditions.
Host Dr. Kevin Passero and his special guest Dr. Cheryl K. Burdette will be discussing integrative oncology.
Dr. Cheryl K. Burdette, ND is a member of the Board of Advisors for Xymogen. She is also president and education director of NutraTest Labs where she is involved in clinical trials of nutraceutical products and the development of functional testing profiles. This position gives her a unique perspective in evidence-based natural therapies.